Philipp A. Reuken
- Hepatology top 5%
- Liver Disease and Transplantation 19
- Neurology top 5%
- Long-Term Effects of COVID-19 26
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies 8
- Clostridium difficile and Clostridium perfringens research 8
- Epidemiology top 10%
- Liver Disease Diagnosis and Treatment 16
- Microscopic Colitis 7
-
- COVID-19 and Mental Health 10
-
- Fibromyalgia and Chronic Fatigue Syndrome Research 9
- Co-authors
- Andreas StallmachTony BrunsPhilip GrunertMathias W. PletzMichael BauerKathrin FinkeNiels TeichSven Stengel
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Philipp A. Reuken
82 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Hepatology 257
- Neurology 333
- Critical Care and Intensive Care Medicine 109
- Infectious Diseases 269
- Epidemiology 356
Countries citing papers authored by Philipp A. Reuken
This map shows the geographic impact of Philipp A. Reuken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp A. Reuken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp A. Reuken more than expected).
Fields of papers citing papers by Philipp A. Reuken
This network shows the impact of papers produced by Philipp A. Reuken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp A. Reuken. The network helps show where Philipp A. Reuken may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Philipp A. Reuken, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 10 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 13 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 3 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 10 | |
| 11 | 2022 | 5 | |
| 12 | 2022 | 2 | |
| 13 | 2022 | 24 | |
| 14 | 2021 | 3 | |
| 15 | 2021 | 11 | |
| 16 | 2021 | 0 | |
| 17 | 2020 | 3 | |
| 18 | 2020 | 36 | |
| 19 | 2019 | 7 | |
| 20 | 2016 | 34 |
About Philipp A. Reuken
Philipp A. Reuken is a scholar working on Hepatology, Critical Care and Intensive Care Medicine and Neurology, having authored 88 papers that have together received 1.2k indexed citations. Recurring topics across this work include Long-Term Effects of COVID-19 (26 papers), Liver Disease and Transplantation (19 papers), Liver Disease Diagnosis and Treatment (16 papers), COVID-19 and Mental Health (10 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (9 papers), COVID-19 Clinical Research Studies (8 papers), Clostridium difficile and Clostridium perfringens research (8 papers) and Microscopic Colitis (7 papers). The work is most often cited by research in Hepatology (257 citations), Neurology (333 citations) and Critical Care and Intensive Care Medicine (109 citations). Philipp A. Reuken has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Andreas Stallmach, Tony Bruns, Philip Grunert, Mathias W. Pletz, Michael Bauer, Kathrin Finke, Niels Teich, Sven Stengel, Stefanie Quickert and Michael Baier. Their work appears in journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.